<DOC>
	<DOCNO>NCT00821548</DOCNO>
	<brief_summary>The investigator evaluate clinical tolerance , biological tolerance , feasibility efficacy daily electrostimulation training shoulder girdle quadriceps muscle 10 patient facioscapulohumeral muscular dystrophy , third common inherit myopathy .</brief_summary>
	<brief_title>Electrostimulation Shoulder Girdle Quadriceps Muscles Facioscapulohumeral Muscular Dystrophy Patients</brief_title>
	<detailed_description>Autosomal dominant FSHD characterize selective pattern muscle involvement . Weakness atrophy typically involve facial shoulder girdle muscle , progressively anterior forearm foreleg muscle pelvic girdle muscle . The physiopatholgical mechanism disease , due deletion repeat unit name D4Z4 locate 4q35 , still controversial . Up date , curative therapy available patient . We propose present study test feasibility , clinical biological tolerance efficacy shoulder muscle train electrostimulation group FSHD patient . 10 patient display classical FSHD phenotype participate study consist daily session shoulder girdle quadriceps muscle electrostimulation 23 minute period 5 month . We evaluate : clinical tolerance daily pain fatigue analogic scale , biological tolerance measure CK ; feasibility : measuring monthly score participation session ; efficacy manual muscle testing , quantitative muscle assessment , fatigue severity scale .</detailed_description>
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Muscular Dystrophy , Facioscapulohumeral</mesh_term>
	<criteria>18 75 year old patient FSHD diagnosis confirm molecular biology FSHD clinical phenotype include shoulder girdle quadriceps involvement Patient Vignos scale â‰¤ 5 ( patient able walk ) Patient health insurance Patient could follow least 6 month Patient monolateral bilateral scapular omopexia Patient already electrostimulation train Patients CK value &gt; 5 time normal value Patient sign informed consent Patient cancer , collagenopathies others joint disease Pregnancy breastfeed Patient guardianship trusteeship . Patient actively participate biomedical research whose exclusion period end Patient formal contraindication protocol detect inclusion examination</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>facioscapulohumeral muscular dystrophy</keyword>
	<keyword>electrostimulation</keyword>
	<keyword>training</keyword>
</DOC>